Suppr超能文献

高血压中枢神经系统中的肾素-血管紧张素系统与交感神经递质释放

Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension.

作者信息

Tsuda Kazushi

机构信息

Cardiovascular and Metabolic Research Center, Kansai University of Health Sciences, Osaka 590-0482, Japan ; Division of Cardiology, Department of Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.

出版信息

Int J Hypertens. 2012;2012:474870. doi: 10.1155/2012/474870. Epub 2012 Nov 21.

Abstract

Many Studies suggest that changes in sympathetic nerve activity in the central nervous system might have a crucial role in blood pressure control. The present paper discusses evidence in support of the concept that the brain renin-angiotensin system (RAS) might be linked to sympathetic nerve activity in hypertension. The amount of neurotransmitter release from sympathetic nerve endings can be regulated by presynaptic receptors located on nerve terminals. It has been proposed that alterations in sympathetic nervous activity in the central nervous system of hypertension might be partially due to abnormalities in presynaptic modulation of neurotransmitter release. Recent evidence indicates that all components of the RAS have been identified in the brain. It has been proposed that the brain RAS may actively participate in the modulation of neurotransmitter release and influence the central sympathetic outflow to the periphery. This paper summarizes the results of studies to evaluate the possible relationship between the brain RAS and sympathetic neurotransmitter release in the central nervous system of hypertension.

摘要

许多研究表明,中枢神经系统交感神经活动的变化可能在血压控制中起关键作用。本文讨论了支持大脑肾素-血管紧张素系统(RAS)可能与高血压患者交感神经活动相关这一概念的证据。交感神经末梢释放的神经递质数量可由位于神经末梢的突触前受体调节。有人提出,高血压患者中枢神经系统交感神经活动的改变可能部分归因于神经递质释放的突触前调节异常。最近的证据表明,RAS的所有成分在大脑中均已被识别。有人提出,大脑RAS可能积极参与神经递质释放的调节,并影响中枢向外周的交感神经输出。本文总结了各项研究的结果,以评估大脑RAS与高血压患者中枢神经系统交感神经递质释放之间的可能关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f602/3512297/9f0ef70a975c/IJHT2012-474870.001.jpg

相似文献

1
Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension.
Int J Hypertens. 2012;2012:474870. doi: 10.1155/2012/474870. Epub 2012 Nov 21.
2
Presynaptic regulation of neurotransmitter release in hypertension.
Clin Exp Pharmacol Physiol. 1991 Jul;18(7):455-67. doi: 10.1111/j.1440-1681.1991.tb01478.x.
3
Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension.
Am J Physiol Heart Circ Physiol. 2006 Apr;290(4):H1706-12. doi: 10.1152/ajpheart.00885.2005. Epub 2005 Nov 11.
5
Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems.
J Cardiovasc Pharmacol. 1992;19 Suppl 6:S80-8. doi: 10.1097/00005344-199219006-00013.
8
Sympathetic amines, renin and blood pressure.
Acta Endocrinol Suppl (Copenh). 1978;216:67-74.

引用本文的文献

1
Angiotensin II and Atherosclerosis: A New Cardiovascular Risk Factor Beyond Hypertension.
Int J Mol Sci. 2025 Aug 4;26(15):7527. doi: 10.3390/ijms26157527.
2
Finerenone: A Novel Drug Discovery for the Treatment of Chronic Kidney Disease.
Curr Drug Discov Technol. 2024;21(6):e290124226291. doi: 10.2174/0115701638283354240103115420.
3
Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
Anal Cell Pathol (Amst). 2023 Aug 4;2023:8883492. doi: 10.1155/2023/8883492. eCollection 2023.
4
Cardiac Complications of Hypertensive Emergency: Classification, Diagnosis and Management Challenges.
J Cardiovasc Dev Dis. 2022 Aug 17;9(8):276. doi: 10.3390/jcdd9080276.
5
Effect of ArtemiC in patients with COVID-19: A Phase II prospective study.
J Cell Mol Med. 2022 Jun;26(11):3281-3289. doi: 10.1111/jcmm.17337. Epub 2022 May 19.
6
SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients.
Geroscience. 2022 Apr;44(2):547-565. doi: 10.1007/s11357-022-00528-0. Epub 2022 Feb 14.
7
COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception-A Systematic Review.
Front Neurol. 2021 Jan 28;11:607221. doi: 10.3389/fneur.2020.607221. eCollection 2020.
8
Brain Renin-Angiotensin System at the Intersect of Physical and Cognitive Frailty.
Front Neurosci. 2020 Sep 30;14:586314. doi: 10.3389/fnins.2020.586314. eCollection 2020.
10
Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
JAMA Netw Open. 2019 Oct 2;2(10):e1913304. doi: 10.1001/jamanetworkopen.2019.13304.

本文引用的文献

1
Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients.
Hypertension. 2012 Aug;60(2):319-25. doi: 10.1161/HYPERTENSIONAHA.112.194787. Epub 2012 Jun 25.
2
Central sympathetic inhibition by mineralocorticoid receptor but not angiotensin II type 1 receptor blockade: are prescribed doses too low?
Hypertension. 2012 Aug;60(2):278-80. doi: 10.1161/HYPERTENSIONAHA.112.197012. Epub 2012 Jun 25.
3
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview.
Expert Opin Drug Saf. 2012 Jul;11(4):659-70. doi: 10.1517/14740338.2012.696608.
6
Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension.
Hypertension. 2012 Jun;59(6):1188-94. doi: 10.1161/HYPERTENSIONAHA.111.190108. Epub 2012 Apr 23.
7
Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.
Expert Opin Ther Pat. 2012 May;22(5):567-74. doi: 10.1517/13543776.2012.682572. Epub 2012 Apr 18.
10
Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients.
Eur Heart J. 2012 Jun;33(12):1530-8. doi: 10.1093/eurheartj/ehs057. Epub 2012 Mar 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验